| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $17,789,350 ) (Continued on the next page) |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA271431 | STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22 | 000 | 2 | NIH | 1/29/2024 | $535,979 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK092460 | Fat in Pancreatitis - a Focus on Hypertriglyceridemic Pancreatitis | 001 | 14 | NIH | 5/13/2024 | $28,722 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK092460 | Fat in Pancreatitis - a Focus on Hypertriglyceridemic Pancreatitis | 000 | 14 | NIH | 12/12/2023 | $430,867 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 001 | 6 | NIH | 6/24/2024 | $51,580 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 000 | 6 | NIH | 11/8/2023 | $580,262 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL172784 | Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium | 000 | 1 | NIH | 3/29/2024 | $688,146 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AA031257 | Biomarkers and pathogenesis of Alcoholic acute pancreatitis | 001 | 1 | NIH | 5/13/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AA031257 | Biomarkers and pathogenesis of Alcoholic acute pancreatitis | 000 | 1 | NIH | 2/29/2024 | $608,856 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R56AI181754 | Roles of Group 2 Innate Lymphoid Cells in Asthma | 000 | 1 | NIH | 5/3/2024 | $480,218 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 004 | 2 | NIH | 1/18/2024 | $291,041 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 002 | 2 | NIH | 1/9/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 001 | 2 | NIH | 12/18/2023 | $373,856 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI175813 | Delineating mechanisms underlying the enhanced stability and functionality of CD2- KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation | 001 | 3 | NIH | 5/17/2024 | $20,811 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI175813 | Delineating mechanisms underlying the enhanced stability and functionality of CD2- KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation | 000 | 3 | NIH | 12/6/2023 | $187,314 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AG080037 | The role of lymph node structural organization in naïve T cell decline with age | 000 | 2 | NIH | 5/2/2024 | $591,539 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI176254 | Tools for reversible short-term degradation of TCF-1 to address its molecular functions | 001 | 2 | NIH | 5/23/2024 | $20,750 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI176254 | Tools for reversible short-term degradation of TCF-1 to address its molecular functions | 000 | 2 | NIH | 2/23/2024 | $186,750 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R13DC021115 | Society of Ears, Nose, and Throat Advances in Children (SENTAC) | 000 | 2 | NIH | 3/6/2024 | $40,000 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI169530 | Allergen-induced extracellular DNA in type 2 immunity | 000 | 3 | NIH | 7/17/2024 | $631,168 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL165176 | Biomaterials for embolization and ablation of arterio-venous malformations | 000 | 3 | NIH | 6/27/2024 | $595,892 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 001 | 4 | NIH | 4/18/2024 | $17,221 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 1/30/2024 | $308,488 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI170649 | Control of antiviral memory CD8+ T cell longevity by extracellular ATP sensing | 000 | 3 | NIH | 6/24/2024 | $473,714 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K23AG073525 | Neurodegeneration and Neuronal Fluctuations in DLB and AD | 004 | 4 | NIH | 5/20/2024 | $154,324 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL156855 | Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | 000 | 3 | NIH | 6/18/2024 | $654,653 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K23AI158813 | Mechanisms of adverse gastrointestinal events during oral immunotherapy | 000 | 3 | NIH | 6/17/2024 | $189,864 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK132651 | Role of SIRT7 in the Pancreatic Beta Cells | 001 | 3 | NIH | 5/3/2024 | $24,847 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK132651 | Role of SIRT7 in the Pancreatic Beta Cells | 000 | 3 | NIH | 3/20/2024 | $372,706 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK130566 | Healing enterocutaneous fistulas using bioengineered biomaterials | 001 | 3 | NIH | 5/9/2024 | $34,240 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK130566 | Healing enterocutaneous fistulas using bioengineered biomaterials | 000 | 3 | NIH | 11/9/2023 | $513,592 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA257558 | Drug eluting injectable biomaterials for next generation chemoembolization | 000 | 4 | NIH | 4/5/2024 | $587,009 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 003 | 4 | NIH | 4/18/2024 | $5,025 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 002 | 4 | NIH | 4/18/2024 | $33,356 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 000 | 4 | NIH | 3/4/2024 | $600,426 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 001 | 4 | NIH | 3/6/2024 | $90,449 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37CA252060 | Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training | 003 | 4 | NIH | 7/11/2024 | $515,850 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R13DC019564 | International Conference on Advances in Quantitative Laryngology,Voice and Speech Research (AQL) | 000 | 4 | NIH | 1/10/2024 | $2,000 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK125680 | A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms | 004 | 4 | NIH | 6/10/2024 | $518,756 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI147652 | Molecular functions of Tcf-1 in DP thymocytes | 001 | 6 | NIH | 5/15/2024 | $41,500 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI147652 | Molecular functions of Tcf-1 in DP thymocytes | 000 | 6 | NIH | 10/26/2023 | $373,500 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37AI071106 | Mechanisms of Allergen-induced Type 2 Immunity | 000 | 18 | NIH | 4/15/2024 | $578,847 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R35GM155031 | Engineering cell-based therapy for enhanced survival and durable function in vivo | 000 | 1 | NIH | 7/23/2024 | $416,250 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL162747 | Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | 001 | 2 | NIH | 6/26/2024 | $57,962 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL162747 | Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | 000 | 2 | NIH | 1/4/2024 | $652,089 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL167811 | Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | 000 | 1 | NIH | 12/11/2023 | $698,520 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI128729 | Mechanisms of IL-33 secretion in allergic diseases | 001 | 8 | NIH | 5/24/2024 | $60,455 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI128729 | Mechanisms of IL-33 secretion in allergic diseases | 000 | 8 | NIH | 1/29/2024 | $544,098 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 001 | 3 | NIH | 6/12/2024 | $46,164 |
| 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 000 | 3 | NIH | 11/10/2023 | $415,470 |
|